Systemic sclerosis (scleroderma) trials in Israel
8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Haifa, Kfar Saba
- Age
- 5 years to 80 years
- People
- 1,072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - Phase 3Taking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Haifa, Kfar Saba, Ramat Gan
- Age
- 18 years and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - Phase 3Taking peopleA Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- Where
- Poria – Neve Oved
- Age
- 18 years and over
- People
- 514 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06716606 - Phase 2/3Taking peopleA Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- Where
- Haifa, Holon, Kfar Saba, Ramat Gan, Tel Aviv, Tiberias
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01 - Phase 1Taking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Jerusalem, Ramat Gan
- Age
- 18 years and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00 - Phase 1Taking peoplePhase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
- Where
- Jerusalem
- Age
- 18 years to 80 years
- People
- 120
- Run by
- Polina Stepensky
See details and how to joinNCT07085676 - No phaseTaking peopleEFESO: Study on Juvenile Onset Eosinophilic Fasciitis
- Where
- Haifa
- Age
- Up to 18 years
- People
- 20 worldwide
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT07348263 - No phaseTaking peopleMeir Medical Center Rheumatologic Biobank
- Where
- Kfar Saba
- Age
- 18 years to 120 years
- People
- 500
- Run by
- Meir Medical Center
See details and how to joinNCT03473912